Our study first noticed a significant increase in serum IFN-γ in moderate and severe COVID-19 patients, and IFN-γ with antiviral ability was also characterized to be associated with the titre of the neutralizing antibody in COVID-19 patients [53]. This evidence concerns the gene IFNG and COVID-19.